Calcium-activated Endoplasmic Reticulum Stress as a Major Component of Tumor Cell Death Induced by 2,5-dimethyl-celecoxib, a Non-coxib Analogue of Celecoxib
Peter Pyrko ; Adel Kardosh ; Yen-Ting Liu ; Nathaniel Soriano ; Wenyong Xiong ; Robert H Chow ; Jasim Uddin ; Nicos A Petasis ; Austin K Mircheff ; Robert A Farley ; Stan G Louie ; Thomas C Chen ; Axel H Schönthal
2007
发表期刊Molecular Cancer Theraputics
卷号6期号:4页码:1262-1275
摘要A drawback of extensive coxib use for antitumor purposes is the risk of life-threatening side effects that are thought to be a class effect and probably due to the resulting imbalance of eicosanoid levels. 2,5-Dimethyl-celecoxib (DMC) is a close structural analogue of the selective cyclooxygenase-2 inhibitor celecoxib that lacks cyclooxygenase-2–inhibitory function but that nonetheless is able to potently mimic the antitumor effects of celecoxib in vitro and in vivo. To further establish the potential usefulness of DMC as an anticancer agent, we compared DMC and various coxibs and nonsteroidal anti-inflammatory drugs with regard to their ability to stimulate the endoplasmic reticulum (ER) stress response (ESR) and subsequent apoptotic cell death. We show that DMC increases intracellular free calcium levels and potently triggers the ESR in various tumor cell lines, as indicated by transient inhibition of protein synthesis, activation of ER stress–associated proteins GRP78/BiP, CHOP/GADD153, and caspase-4, and subsequent tumor cell death. Small interfering RNA–mediated knockdown of the protective chaperone GRP78 further sensitizes tumor cells to killing by DMC, whereas inhibition of caspase-4 prevents drug-induced apoptosis. In comparison, celecoxib less potently replicates these effects of DMC, whereas none of the other tested coxibs (rofecoxib and valdecoxib) or traditional nonsteroidal anti-inflammatory drugs (flurbiprofen, indomethacin, and sulindac) trigger the ESR or cause apoptosis at comparable concentrations. The effects of DMC are not restricted to in vitro conditions, as this drug also generates ER stress in xenografted tumor cells in vivo, concomitant with increased apoptosis and reduced tumor growth. We propose that it might be worthwhile to further evaluate the potential of DMC as a non-coxib alternative to celecoxib for anticancer purposes.
文献类型期刊论文
条目标识符http://ir.kib.ac.cn/handle/151853/17707
专题植物化学与西部植物资源持续利用国家重点实验室
推荐引用方式
GB/T 7714
Peter Pyrko,Adel Kardosh,Yen-Ting Liu,et al. Calcium-activated Endoplasmic Reticulum Stress as a Major Component of Tumor Cell Death Induced by 2,5-dimethyl-celecoxib, a Non-coxib Analogue of Celecoxib[J]. Molecular Cancer Theraputics,2007,6(4):1262-1275.
APA Peter Pyrko.,Adel Kardosh.,Yen-Ting Liu.,Nathaniel Soriano.,Wenyong Xiong.,...&Axel H Schönthal.(2007).Calcium-activated Endoplasmic Reticulum Stress as a Major Component of Tumor Cell Death Induced by 2,5-dimethyl-celecoxib, a Non-coxib Analogue of Celecoxib.Molecular Cancer Theraputics,6(4),1262-1275.
MLA Peter Pyrko,et al."Calcium-activated Endoplasmic Reticulum Stress as a Major Component of Tumor Cell Death Induced by 2,5-dimethyl-celecoxib, a Non-coxib Analogue of Celecoxib".Molecular Cancer Theraputics 6.4(2007):1262-1275.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
8.Calcium-activated (732KB) 开放获取CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Peter Pyrko]的文章
[Adel Kardosh]的文章
[Yen-Ting Liu]的文章
百度学术
百度学术中相似的文章
[Peter Pyrko]的文章
[Adel Kardosh]的文章
[Yen-Ting Liu]的文章
必应学术
必应学术中相似的文章
[Peter Pyrko]的文章
[Adel Kardosh]的文章
[Yen-Ting Liu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。